Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology by Karin Dijkman, Rhea N. Coler, Rhea N. Coler, Rhea N. Coler, Simone A. Joosten

Get full text

Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis? by Sasha E. Larsen, Susan L. Baldwin, Rhea N. Coler

Get full text

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection by Susan L. Baldwin, Fan-Chi Hsu, Neal Van Hoeven, Emily Gage, Brian Granger, Jeffrey A. Guderian, Sasha E. Larsen, Erica C. Lorenzo, Laura Haynes, Steven G. Reed, Rhea N. Coler, Rhea N. Coler, Rhea N. Coler

Get full text

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations by Susan L. Baldwin, Valerie A. Reese, Sasha E. Larsen, Tiffany Pecor, Bryan P. Brown, Brian Granger, Brendan K. Podell, Christopher B. Fox, Christopher B. Fox, Steven G. Reed, Rhea N. Coler, Rhea N. Coler, Rhea N. Coler

Get full text

SARS-CoV-2 infection and immune responses by Rakhi Harne, Brittany Williams, Hazem F. M. Abdelal, Susan L. Baldwin, Rhea N. Coler

Get full text

<i>Mycobacterium abscessus</i>: It’s Complex by Hazem F. M. Abdelaal, Edward D. Chan, Lisa Young, Susan L. Baldwin, Rhea N. Coler

Get full text

Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal leishmaniasis refractory to antimony: a case report by Roberto Badaro, Iza Lobo, Maria Nakatani, Alvaro Muiños, Eduardo M. Netto, Rhea N. Coler, Steven G. Reed

Get full text

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction. by Natasha Dubois Cauwelaert, Anthony L Desbien, Thomas E Hudson, Samuel O Pine, Steven G Reed, Rhea N Coler, Mark T Orr

Get full text

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment by Sasha E. Larsen, Susan L. Baldwin, Mark T. Orr, Valerie A. Reese, Tiffany Pecor, Brian Granger, Natasha Dubois Cauwelaert, Brendan K. Podell, Rhea N. Coler

Get full text

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. by Susan L Baldwin, Valerie A Reese, Sasha E Larsen, Elyse Beebe, Jeff Guderian, Mark T Orr, Christopher B Fox, Steven G Reed, Rhea N Coler

Get full text

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140. by Mauricio A Arias, Griet A Van Roey, John S Tregoning, Magdalini Moutaftsi, Rhea N Coler, Hillarie P Windish, Steven G Reed, Darrick Carter, Robin J Shattock

Get full text

Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective a... by Ju Mi Lee, Jiyun Park, Steven G Reed, Rhea N Coler, Jung Joo Hong, Lee-Han Kim, Wonsik Lee, Kee Woong Kwon, Sung Jae Shin

Get full text

Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration by Sara E. Maloney, Ian E. Stewart, Brendan K. Podell, Hadley E. Gary, Jeffrey B. Mecham, Bryan J. Berube, Susan L. Baldwin, Rhea N. Coler, Anthony J. Hickey

Get full text

An RNA-Based Vaccine Platform for Use against <i>Mycobacterium tuberculosis</i> by Sasha E. Larsen, Jesse H. Erasmus, Valerie A. Reese, Tiffany Pecor, Jacob Archer, Amit Kandahar, Fan-Chi Hsu, Katrina Nicholes, Steven G. Reed, Susan L. Baldwin, Rhea N. Coler

Get full text

Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models by Sasha E. Larsen, Valerie A. Reese, Tiffany Pecor, Bryan J. Berube, Sarah K. Cooper, Guy Brewer, Diane Ordway, Marcela Henao-Tamayo, Brendan K. Podell, Susan L. Baldwin, Rhea N. Coler

Get full text

Adjuvants influence the maturation of VRC01-like antibodies during immunization by Maria L. Knudsen, Parul Agrawal, Anna MacCamy, K. Rachael Parks, Matthew D. Gray, Brittany N. Takushi, Arineh Khechaduri, Kelsey R. Salladay, Rhea N. Coler, Celia C. LaBranche, David Montefiori, Leonidas Stamatatos

Get full text

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. by Rhea N Coler, Sylvie Bertholet, Magdalini Moutaftsi, Jeff A Guderian, Hillarie Plessner Windish, Susan L Baldwin, Elsa M Laughlin, Malcolm S Duthie, Christopher B Fox, Darrick Carter, Martin Friede, Thomas S Vedvick, Steven G Reed

Get full text

Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis. by Pedro Cecílio, Begoña Pérez-Cabezas, Laura Fernández, Javier Moreno, Eugenia Carrillo, José M Requena, Epifanio Fichera, Steven G Reed, Rhea N Coler, Shaden Kamhawi, Fabiano Oliveira, Jesus G Valenzuela, Luigi Gradoni, Reinhard Glueck, Gaurav Gupta, Anabela Cordeiro-da-Silva

Get full text

Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection by Jesse H. Erasmus, Jacob Archer, Jasmine Fuerte-Stone, Amit P. Khandhar, Emily Voigt, Brian Granger, Robin G. Bombardi, Jennifer Govero, Qing Tan, Lorellin A. Durnell, Rhea N. Coler, Michael S. Diamond, James E. Crowe, Jr., Steven G. Reed, Larissa B. Thackray, Robert H. Carnahan, Neal Van Hoeven

Get full text

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial by Yu Hwa Choi, Young Ae Kang, Kwang Joo Park, Jae Chol Choi, Kwan Goo Cho, Da Yeon Ko, Jun Ho Ahn, Boram Lee, Eunsol Ahn, Yun Ju Woo, Kwangsoo Jung, Nan Yul Kim, Valerie A. Reese, Sasha E. Larsen, Susan L. Baldwin, Steven G. Reed, Rhea N. Coler, Hyejon Lee, Sang-Nae Cho

Get full text